Ready to contact us for a consultation about your condition and our medical services? The staff of our International Medical Tourism Division is ready to help.
Please select the appropriate button to get started.
Professor Dan Aderka is the head of the Gastrointestinal Cancer Service and chief specialist in the field of Digestive System Oncology.
Professor Aderka was involved in the planning and execution of clinical trials for the 1st, 2nd, and 3rd phases of the digestive system cancer treatment. In collaboration with the Weizmann Institute of Science professor Aderka carried out several academic research in the field of Tumor Necrosis Factor – TNF.
During his career professor Aderka has published more than 130 articles in various scientific journals.
He is the member of the Israeli Association of Clinical Oncology and Radiotherapy (ISCORT), the American Society of Oncology (ASCO) and the European Oncology Society (ESMO).
Positions
Head of the Gastrointestinal Cancer Service
Professor at the Sackler Medical School, Tel Aviv University, Israel
Credentials
Education and Training
Graduated Sackler Medical School at Tel Aviv University
Chemotherapy, often referred to as “chemo,” is a type of treatment for cancer that uses medication or a combination of different medications. Read More >>
CAR T therapy is a revolutionary type of blood cancer treatment that programs a patient’s own altered white blood cells to kill cancer cells. Read More >>
Targeted therapy drugs are officially classified as biological treatment. Targeted therapy can be used alone, but it is more often used in conjunction with other cancer treatments. Read More >>
Radiation therapy, also called radiotherapy or irradiation, is one of the most common approaches to cancer therapy. Over half of all people with cancer will be treated with radiation therapy. Read More >>
This is the excerpt. Acute Lymphoblastic Leukemia (ALL) is the most common cancer in children. It is a type of blood and bone marrow cancer that progresses quickly. Read More >>
CML is a type of cancer that originates in the blood-forming cells of the bone marrow. Typically, CML is a slow growing disease, although this disease can later transform into a fast growing acute leukemia. Read More >>
Ewing Sarcoma is a type of cancer that originates in the bone or soft tissue around the bone. It is most commonly discovered in children and teens. Read More >>
A glioma is a type of brain or spinal cord tumor that begins in glial cells, supportive cells that surround the neurons in your brain, nourishing and insulating them. Read More >>
Chronic Lymphocytic Leukemia (CLL) is the most common form of leukemia in adults and accounts for approximately one-third of all leukemias. Read More >>
CML is a type of cancer that originates in the blood-forming cells of the bone marrow and leads to the production of too many mature white blood cells. Read More >>
Non-Hodgkin Lymphoma (NHL), also called non-Hodgkin’s lymphoma or lymphoma, is a type of cancer that originates in the lymphocytes, or white blood cells. Read More >>
Myelodysplastic syndromes (MDS) are cancers that originate in the bone marrow and affect the growth of blood cells so the body cannot function properly. Read More >>
Multiple myeloma is a blood cancer (related to lymphoma and leukemia) that originates in the plasma cells, which are essential components of your immune system. Read More >>
MF originates in the bone marrow, where it causes fibrous scar tissue to replace the healthy, soft and spongy tissue that is normally inside your bones. Read More >>
Request a Call Back from a
Medical Case Manager at Sheba
Request a Call Back from a
Medical Case Manager at Sheba
Cookies
We have placed cookies on your device to improve your experience on our website, to analyze our traffic and to make assumptions on what advertising may interest you. If you continue to browse we will assume that you are happy with our cookies. Find out more.
